- Adjusted pretax profit for Spectris in the first half of 2025 was £48.7 million, a 22% decrease year-on-year, missing the estimated £61.4 million.
- Sales reached £636.1 million, a 7.9% increase year-on-year, surpassing the estimated £623.5 million.
- Spectris Scientific’s sales grew by 21% year-on-year to £386.0 million, exceeding the £373.4 million estimate.
- Spectris Dynamics achieved sales of £250.1 million, slightly above the £244.1 million estimate.
- Adjusted operating profit rose 7.4% year-on-year to £65.6 million, falling short of the expected £71.6 million.
- The interim dividend per share was set at 28.0p, surpassing the estimated 27.8p.
- Spectris anticipates its full-year adjusted operating profit to align with expectations, supported by improved sales and order momentum.
- The company plans to leverage benefits from recent acquisitions and efficiency programs, aiming to return its leverage to within the 1-2x target range by the end of 2025.
- Spectris is achieving strong synergies from acquisitions and expects its Profit Improvement Programme to deliver over £30 million in savings in 2025, with two-thirds of it occurring in the second half of the year.
- The stock has received 7 buy ratings, 3 hold ratings, and no sell ratings from analysts.
Spectris PLC on Smartkarma
Analysts on Smartkarma, such as Jesus Rodriguez Aguilar, are closely monitoring the intense bidding war surrounding Spectris PLC. Advent has raised its bid to £40.72 per share, surpassing KKR’s previous offer, with significant board support and a 7.54% stake secured. This move by Advent brings the UK’s largest industrial tech buyout closer to fruition, stirring competition and prompting a revised board recommendation. Despite the minimal spread, this development sheds light on pricing discipline, sponsor credibility, and the shifting M&A landscape in the UK.
In another update, KKR has now gained board approval for its £40 per share counter-offer for Spectris, displacing Advent’s previous bid. The market anticipates a high deal certainty with near-zero spread and limited regulatory hurdles. With the situation favoring KKR, unless Advent swiftly counters, closure seems imminent. Analysts are closely watching these developments, as the competitive bidding signals evolving dynamics in the UK market amidst private equity competition for British assets.
A look at Spectris PLC Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Investors looking at the long-term outlook for Spectris PLC can find encouragement in the Smartkarma Smart Scores. With a strong momentum score of 5, Spectris PLC is showing solid growth potential for the future. This positive momentum is complemented by a growth score of 4, indicating that the company is well-positioned for expansion and development in its industry.
Furthermore, Spectris PLC also scores well in resilience and dividend, with scores of 3 in each category. This suggests that the company has a stable foundation and is able to weather economic uncertainties, providing a reliable investment option. Although the value score is slightly lower at 2, the overall outlook for Spectris PLC appears promising, making it a company to watch for potential long-term growth and stability.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
